பிரகாசமான மனங்கள் உயிர் அறிவியல் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பிரகாசமான மனங்கள் உயிர் அறிவியல் இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பிரகாசமான மனங்கள் உயிர் அறிவியல் இன்க் Today - Breaking & Trending Today

New Research Finds Promise in Psychiatric Use Of Psilocybin North American Companies Explore Full Potential


(MENAFN - Baystreet.ca) A new study led by the Imperial College London s Centre for Psychedelic Research has yielded promising results for the use of psilocybin in psychiatric therapy.
Psilocybin, the psychoactive compound of magic mushrooms - was pitted up against popular SSRI (selective serotonin reuptake inhibitor) escitalopram. Results were measured through scoring tallied after surveying participants on their sleep, energy, appetite, mood and suicidal ideations.
The largely-negatively focused questionnaire attained similar results for both the SSRI and the psilocybin group - an already promising result. However, some markers that were not originally part of the study showed far superior results in the psilocybin group. Namely, measures of work and social functioning, mental well-being and the ability to feel happy. ....

United States , United Kingdom , Castle Rising , City Of , British Columbia , Kathryna Cunningham , Ian Mcdonald , George Goldsmith , Imperial College London Centre For Psychedelic Research , Addiction Research , Bright Minds Biosciences Inc , University Of Texas Medical Branch , Imperial College London , Psychedelic Research , North American , Compass Pathways , Bright Minds , Minds Biosciences , Bright Future , Bright Mind , Texas Medical , North America , Texas Medical Branch , Bright Minds Biosciences , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் ,

Bright Minds Biosciences Announces Closing of $25.9 Million Unit Offering


Article content
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.
VANCOUVER, British Columbia, March 17, 2021 (GLOBE NEWSWIRE) Bright Minds Biosciences Inc. (CSE:DRUG) (“Bright Minds” or the “Company”) is pleased to announce that it has closed its previously announced underwritten public offering (the “Offering”) of units (the “Units”) of the Company. Eight Capital acted as lead underwriter and sole bookrunner in connection with the Offering on behalf of a syndicate of underwriters including Stifel GMP, Beacon Securities Limited and Haywood Securities Inc. (collectively, the “Underwriters”). ....

United States , United Kingdom , British Columbia , Lisam Wilson , Beacon Securities , Canadian Securities Exchange , Bright Minds Biosciences Inc , Units Of The Company , Haywood Securities Inc , Bright Minds Biosciences , Eight Capital , Beacon Securities Limited , Haywood Securities , Each Warrant , Common Shares , Common Share , United States Securities Act , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , பிரிட்டிஷ் கொலம்பியா , பெக்கான் பத்திரங்கள் , கனடியன் பத்திரங்கள் பரிமாற்றம் , பிரகாசமான மனங்கள் உயிர் அறிவியல் இன்க் , அலகுகள் ஆஃப் தி நிறுவனம் , வைக்கோல் பத்திரங்கள் இன்க் , பிரகாசமான மனங்கள் உயிர் அறிவியல் ,

Bright Minds Biosciences Inc. Announces Marketed Public Offering